Riskpilot← Back to searchSign inGet full accessSARSTEDT ApS
APSActiveCVR 34593531Brogesvej 18Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201224 employees
Revenue 2025
DKK 30,3M
-3% vs 2024
EBITDA margin
41.7%
-15% vs 2024
Equity ratio
63.8%
Financial strength
Net profit 2025
DKK 10M
-13% vs 2024
| Revenue | DKK 30,3M | -3% |
| EBITDA | DKK 12,6M | -15% |
| Net profit | DKK 10M | -13% |
| Total assets | DKK 74M | +28% |
| Equity | DKK 47,2M | +27% |
| Employees | 24 | — |
Legal name
SARSTEDT ApS
CVR number
34593531
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. februar 2012
Share capital
DKK 500.000
Employees
24 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af direktionen alene.
Company purpose
Selskabets formål er at drive virksomhed indenfor udvikling, salg, service og vedligeholdelse af blodprøvetransportsystemer og distribution af varer og instrumenter til medicinsk, videnskabelig og industriel anvendelse samt dermed beslægtet virksomhed.
Address
Brogesvej 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.824 | 5.474 | 6.127 | 10.690 | 18.864 | 16.315 | 19.653 | 24.730 | 10.165 | 7.121 | 57.262 | 30.525 | 30.916 | 31.322 | 30.276 |
| Staff expenses | -2.192 | -3.088 | -3.927 | -4.471 | -6.105 | -8.895 | -11.233 | -14.222 | -13.722 | -5.056 | -13.206 | -14.486 | -15.188 | -16.505 | -17.651 |
| EBITDA | 2.632 | 2.385 | 2.201 | 6.103 | 12.759 | 7.420 | 8.420 | 10.508 | -3.557 | 2.065 | 20.207 | 16.040 | 15.728 | 14.818 | 12.625 |
| Depreciation & amort. | -272 | -449 | -553 | -661 | -816 | -1.017 | -1.048 | -1.221 | -1.349 | -43 | -109 | -436 | -475 | -349 | -139 |
| EBIT | 2.360 | 1.937 | 1.648 | 5.442 | 11.943 | 6.403 | 7.372 | 9.287 | -4.906 | 2.023 | 20.097 | 15.603 | 15.253 | 14.468 | 12.485 |
| Net financials | 1 | -52 | -106 | -266 | -354 | -305 | 1.309 | 1.697 | -953 | -9.152 | -393 | -1.108 | -191 | 346 | 440 |
| Profit before tax | 2.361 | 1.885 | 1.542 | 5.177 | 11.588 | 6.098 | 8.681 | 10.984 | -5.859 | -7.130 | 19.704 | 14.495 | 15.062 | 14.814 | 12.925 |
| Tax | 592 | 371 | 357 | 1.244 | 2.573 | 1.358 | 1.538 | 1.946 | -1.243 | 495 | 4.343 | 3.392 | 3.410 | 3.308 | 2.900 |
| Net profit | 1.769 | 1.514 | 1.185 | 3.933 | 9.015 | 4.740 | 7.143 | 9.038 | -4.615 | -7.625 | 15.362 | 11.102 | 11.653 | 11.505 | 10.026 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7.283 | 10.391 | 10.336 | 22.570 | 28.272 | 30.109 | 36.059 | 40.974 | 36.054 | 46.441 | 28.403 | 40.678 | 52.685 | 57.603 | 74.000 |
| Equity | 2.794 | 4.308 | 5.493 | 9.425 | 14.440 | 14.580 | 14.765 | 19.949 | 9.289 | -17.848 | -2.486 | 8.616 | 20.269 | 37.180 | 47.205 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 469 | 0 | -202 | -159 | -175 | 0 | 0 |
| Short-term debt | 3.336 | 5.329 | 3.864 | 12.136 | 12.733 | 14.499 | 20.121 | 19.489 | 24.952 | 64.149 | 30.602 | 31.771 | 32.134 | 20.138 | 26.142 |
| Total debt | 3.336 | 5.329 | 3.864 | 12.136 | 12.733 | 14.499 | 20.121 | 19.489 | 25.421 | 64.149 | 30.602 | 31.771 | 32.134 | 20.138 | 26.142 |
EBITDA margin
41.7%
This company
15.8%
Market median
+164% vs market
20122025
Equity ratio
63.8%
This company
38.2%
Market median
+67% vs market
20122025
Return on equity
21.2%
This company
18.4%
Market median
+15% vs market
20122025
Net profit margin
33.1%
This company
8.1%
Market median
+309% vs market
20122025
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20122025
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-07-01 – 2020-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RS Management | Management | 2021 | — | — |
DH Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
TS Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2012 | — | — | |
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2025 | |
BLAK HOLDING ApS | Company | 20.0% | 20.0% | 2020 |
BLAK & SØRENSEN ApS | Company | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SARSTEDT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rainer Schuster | Management | 0 companies |
| Daniel Hougård Blak | Chief Executive Officer | 0 companies |
| Timo Schretzmair | Management | 0 companies |
| Finn Dyhre Hansen | Board of Directors | 0 companies |
| Peter Møller Sørensen | Chairman | 0 companies |